• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Events
  • Articles
  • Contact
kentuckiana health collaborative 1

Kentuckiana Health Collaborative

Building a bridge to better health, better care and better value

  • About
    • Mission
    • Staff
    • Board of Directors
  • Strategies
    • Improve Healthcare Quality
    • Make Healthcare More Affordable
    • Build Healthier Communities
  • Initiatives
    • Community Measurement
    • COVID-19
    • Health Equity
    • Kentucky Core Healthcare Measures Set
    • National Hospital Price Transparency Study
    • Opioids and the Workplace
  • Members
    • About the Membership
    • Current Members
    • Member Resources
    • Member Portal
  • Join
Home / Measurement / Measure of the Month: Statin Therapy

Measure of the Month: Statin Therapy

Filed Under: Measurement February 21, 2018, Stephanie Clouser

February is American Heart Month, a time when individuals are reminded to focus on their heart health. February 2 was National Wear Red Day, when you probably saw many people wearing red to raise awareness about cardiovascular disease (CVD), the leading cause of death in the United States.

The Kentuckiana Health Collaborative added two measures to 2017 reporting to reflect the importance of caring for the heart – Statin Therapy for Patients with Cardiovascular Disease and Statin Therapy for Patients with Diabetes. These measures replaced Persistence of Beta-Blocker Treatment after a Heart Attack, which KHC Measurement Strategy Team members decided to discontinue because of low volume of data.

Statin Therapy for Patients with Cardiovascular Disease. This measures the proportion of patients with a diagnosis of clinical atherosclerotic cardiovascular disease (ASCVD) who were given a statin medication to lower LDL cholesterol. There are two rates reported for this measure – whether the individual was dispensed a high- or moderate-intensity statin medication, and whether the individual remained on that statin medication for at least 80 percent of the treatment period. Men at least 21 years old with ASCVD and women at least 40 years old with ASCVD are encouraged to take a statin medication.

Statin Therapy for Patients with Diabetes. This measure looks at statin medication for patients with diabetes that do not have cardiovascular disease. Individuals with diabetes are at a higher risk for developing cardiovascular disease, thought to be due in part to elevations in unhealthy cholesterol levels. The main difference between this measure and the measure above is the intensity of the statin dispensed. While the CVD measure looks for high- or moderate-intensity statin medication, diabetes patients can be dispensed a statin of any intensity and still meet the criteria for the measure.

For more information on Statin Therapy for CVD or Statin Therapy for Diabetes, along with information about hundreds of other measures, you can go to the Agency for Healthcare Research and Quality’s National Quality Measures Clearinghouse website.

Similar Articles

KCHMS Blog Photo

Call for Applications – 2021 KY Core Healthcare Measures Set Committees

December 17, 2020

The Kentuckiana Health Collaborative is filling rosters for the selection of the 2021 Kentucky Core Healthcare Measures set (KCHMS), a core healthcare measures set for Kentucky’s primary care providers, with the ultimate goal of aligning the priorities of Medicare, Medicaid, and commercial insurers. The KCHMS was first released in June […]

Read More

Community Reports Highlight Improvements in Quality Metrics, but the Effects of COVID-19 on Primary Care Remain to be Seen

May 22, 2020

In April, the Kentuckiana Health Collaborative sent private reports to nearly 450 group practices throughout Kentucky and Southern Indiana. Soon after, the KHC released its annual community reports, featuring highlights of where the community performs well and where there are gaps in care. On Thursday, the KHC held a webinar […]

Read More

Kentuckiana Health Collaborative Releases Community Measurement Reports, Collects Data on Opioid Prescribing

April 30, 2020

The Kentuckiana Health Collaborative is pleased to release the 2018 Community Measurement Reports, which also includes opioid prescribing data as part of the KHC’s partnership with the Kentucky Opioid Response Effort (KORE). For the last 15 years, the KHC has led the way in healthcare quality measurement and transparency through […]

Read More

Get the latest articles and updates.

Our email newsletter shares our latest research, initiatives and events.

Footer

  • About
    • Mission
    • Staff
    • Board of Directors
  • Members
    • About the Membership
    • Member Resources
    • Join the Membership
  • Strategies
    • Improve Healthcare Quality
    • Make Healthcare More Affordable
    • Build Healthier Communities
  • Initiatives
    • Community Measurement
    • COVID-19
    • Health Equity
    • National Hospital Price Transparency Study
    • Opioids and the Workplace
  • Connect
    • Events
    • Articles
    • Contact
khc logo blue

(502) 238-3603
1415 Bardstown Road, Mailbox 19, Louisville, KY 40204

Copyright © 2021 · Kentuckiana Health Collaborative · Privacy Policy · Sitemap · Stop Animations

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok